ea0045p34 | Diabetes | BSPED2016
Trewella E F
, Spowart K
, Nambisan A Kesavath Raman
, Nolan SE
, Carr S
, Balfour-Lynn I M
, Alexander Saji
, Bridges Nicola
Introduction: Continuous Subcutaneous Insulin Infusion (CSII) has several advantages over Multiple Daily Injections (MDI) including better hourly delivery and avoidance of injections. However usage of CSII is significantly less in Cystic Fibrosis Related Diabetes (CFRD) compared to type 1 diabetes and published literature on use of CSII in children and adolescents with CFRD is minimal.We report two cases where CSII was used in CFRD resulting in a lower T...